Design, biologic evaluation, and SAR of novel pseudo-peptide incorporating benzheterocycles as HIV-1 protease inhibitors.

作者: Meizi He , Hang Zhang , Xiaojian Yao , Michael Eckart , Elizabeth Zuo

DOI: 10.1111/J.1747-0285.2010.00995.X

关键词:

摘要: A series of novel HIV-1 protease inhibitors based on the (hydroxyethylamino)-sulfonamide isostere incorporating substituted phenyls and benzheterocycle derivatives bearing rich hydrogen bonding acceptors as P2 ligands were synthesized. Prolonged chain linking benzhereocycle to carbonyl group resulted in partial loss binding affinities. Introduction a small alkyl substituent with appropriate size -CH2- P1-P2 linkage side improved inhibitory potency, this study, isopropyl was best chain. Replacement isobutyl at P1′group phenyl decreased potency. One most potent inhibitor, compound 23 showing high affinity an IC50 value 5 nm, also exhibited good anti-SIV activity (EC50 = 0.8 μm) low toxicity (TC50 > 100 μm). The flexible docking inhibitor active site rationalized interactions protease.

参考文章(24)
John P. Moore, Mario Stevenson, New targets for inhibitors of HIV-1 replication. Nature Reviews Molecular Cell Biology. ,vol. 1, pp. 40- 49 ,(2000) , 10.1038/35036060
E DECLERCQ, HIV-chemotherapy and -prophylaxis: new drugs, leads and approaches. The International Journal of Biochemistry & Cell Biology. ,vol. 36, pp. 1800- 1822 ,(2004) , 10.1016/J.BIOCEL.2004.02.015
M. M. H. Arief, SYNTHESIS OF SOME SACCHARIN DERIVATIVES OF EXPECTED BIOLOGICAL ACTIVITY BASED ON N-(SACCHARINYL)-ACETIC ACID AZIDE Phosphorus Sulfur and Silicon and The Related Elements. ,vol. 114, pp. 129- 134 ,(1996) , 10.1080/10426509608046419
Ashraf Brik, Ying-Chuan Lin, John Elder, Chi-Huey Wong, A quick diversity-oriented amide-forming reaction to optimize P-subsite residues of HIV protease inhibitors. Chemistry & Biology. ,vol. 9, pp. 891- 896 ,(2002) , 10.1016/S1074-5521(02)00184-9
Arun K. Ghosh, Bruno D. Chapsal, Irene T. Weber, Hiroaki Mitsuya, Design of HIV protease inhibitors targeting protein backbone: an effective strategy for combating drug resistance. Accounts of Chemical Research. ,vol. 41, pp. 78- 86 ,(2008) , 10.1021/AR7001232
Edgar Specker, Jark Böttcher, Andreas Heine, Christoph A. Sotriffer, Hauke Lilie, Andreas Schoop, Gerhard Müller, Nils Griebenow, Gerhard Klebe, Hydroxyethylene sulfones as a new scaffold to address aspartic proteases: design, synthesis, and structural characterization. Journal of Medicinal Chemistry. ,vol. 48, pp. 6607- 6619 ,(2005) , 10.1021/JM050224Y
Arun K. Ghosh, Zachary L. Dawson, Hiroaki Mitsuya, Darunavir, a Conceptually New HIV-1 Protease Inhibitor for the Treatment of Drug-resistant HIV Bioorganic & Medicinal Chemistry. ,vol. 15, pp. 7576- 7580 ,(2007) , 10.1016/J.BMC.2007.09.010
E. E. Kim, C. T. Baker, M. D. Dwyer, M. A. Murcko, B. G. Rao, R. D. Tung, M. A. Navia, Crystal Structure of HIV-1 Protease in Complex with Vx-478, a Potent and Orally Bioavailable Inhibitor of the Enzyme Journal of the American Chemical Society. ,vol. 117, pp. 1181- 1182 ,(1995) , 10.1021/JA00108A056
John A. Bartlett, Ralph DeMasi, Joseph Quinn, Cary Moxham, Franck Rousseau, Overview of the effectiveness of triple combination therapy in antiretroviral-naive HIV-1 infected adults. AIDS. ,vol. 15, pp. 1369- 1377 ,(2001) , 10.1097/00002030-200107270-00006
Xaioqin Huang, Liaosa Xu, Xiaomin Luo, Kangnian Fan, Ruyun Ji, Gang Pei, Kaixian Chen, Hualiang Jiang, Elucidating the Inhibiting Mode of AHPBA Derivatives against HIV-1 Protease and Building Predictive 3D-QSAR Models Journal of Medicinal Chemistry. ,vol. 45, pp. 333- 343 ,(2002) , 10.1021/JM0102710